ANDA 77592, held by Sun Pharmaceutical Industries. Galantamine Hydrobromide.
As of Nov 21, 2026, ANDA 77592 (Galantamine Hydrobromide), held by Sun Pharmaceutical Industries, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 28, 2007 | Original application | Tentative approval | None posted |
| Galantamine Hydrobromide4MG · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
| Galantamine Hydrobromide8MG · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
| Galantamine Hydrobromide12MG · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters